1. Introduction {#sec1}
===============

Non-typhoidal *Salmonella* infections are important public health problems worldwide \[[@bib1], [@bib2], [@bib3], [@bib4]\]. In the past two decades, the rate of antimicrobial resistance and number of newly identified resistance determinants in *Salmonellae* have increased markedly \[[@bib5], [@bib6], [@bib7], [@bib8]\]. Most *Salmonella* infections are thought to be due to consumption of contaminated food, in particular meat, poultry and dairy products \[[@bib9], [@bib10]\]. Food animals are presumably the major reservoirs of new epidemic strains that often exhibit high level virulence and antimicrobial resistance phenotypes [@bib11]. Typical examples include the *S.* Typhimurium DT104 strain in the UK \[[@bib12], [@bib13]\], *S.* Newport in the US \[[@bib14], [@bib15]\] and *S.* Enteritidis strains that exhibit close association with eggs and chicken \[[@bib16], [@bib17], [@bib18], [@bib19]\]. In response to the growing threat of outbreaks and drug resistance of foodborne pathogens, industrialized nations have implemented numerous intervention approaches designed to reduce the rate of colonization by *Salmonellae* and other foodborne pathogens in food animals and animal-derived products \[[@bib20], [@bib21]\]. To enhance the effectiveness of such measures, efforts have been made to identify factors that determine the pathways of transmission of *Salmonellae* from animals to humans, through assessment of the temporal and spatial distribution of *Salmonella* serotypes in various sources. Comprehensive surveillance programs conducted on both human and animal isolates in the European countries and the U.S. showed that the dominant serotypes that caused human clinical infections were not due to an overwhelming prevalence of these serotypes in animals \[[@bib22], [@bib23]\]. Hence, the determining factors that contribute to *Salmonella* clinical infections are still not well defined. To date, only a few studies have evaluated and compared the diversity of PFGE types of temporally and geographically matched animal and human clinical *Salmonella* isolates \[[@bib24], [@bib25]\]. Efforts to generate information on the serotype and PFGE diversity of clinical strains and zoonotic and foodborne pathogens, which is critical to source-tracking and identification of potentially host-restricted serotypes, have been limited by small sample size and undesirable research design.

In China, *Salmonella* surveillance programs have been confined to human clinical samples. The few previous studies which reported the prevalence of different *Salmonella* serotypes in animals and food products showed that *Salmonella* prevalence rate in China varies wildly between different regions \[[@bib26], [@bib27], [@bib28], [@bib29], [@bib30]\]. Yet there is little information on major food-animal reservoirs of disease-causing *Salmonella* strains, and the corresponding modes of transmission. To fill this knowledge gap, we strived to compare the antimicrobial resistance and serotype distribution of major collections of *Salmonella* strains isolated from both animals and hospital patients in China during the period of 2003--2011, so as to depict the features of transmission of specific serotypes of *Salmonellae* from animals to human. Findings of this work shall help identify the major serotypes and specific strains involved in *Salmonella* infections of zoonotic origin in China.

2. Materials and methods {#sec2}
========================

2.1. Isolation and identification of *Salmonella* strains {#sec2.1}
---------------------------------------------------------

A total of 5926 samples including chicken liver and lung (540), chicken intestinal content (225), chicken meat (671), chicken faeces (1781), swine faeces (1906), pork (291), duck intestinal content (304), and cow faeces (208) collected from the provinces of Sichuan, Guangdong, Jiangxi, Henan, Jiangsu and Shandong in China during the period 2003--2011 were included in this study. Chicken samples were collected from one-day old chick in chicken hatcheries, chicken farms or slaughter houses, duck samples were from slaughter house, swine and cow samples were collected from healthy animals in farms and slaughter house. Samples were collected at least twice in each province every year since 2005.

Fresh samples were pre-enriched in buffered peptone water (BPW, Difco, Cockeysville, MD) and selenite cystine broth (SC, Oxiod), followed by streaking onto CHROMagar *Salmonella* agar (CHROMagar Company, Paris, France) and bismuth sulphite agar (Oxiod). Suspected *Salmonella* colonies were selected for biochemical study using the API 20 E (bioMérieux, Marcy l\' Etoile, France) micro-substrate system for genus identification. The suspected *Salmonella* pullorum strains were subjected to motility test on indole--lysine semisolid agar to determine their mobility.

Clinical *Salmonella* isolates were obtained from stool and blood samples of infected patients in hospitals. Sample collection was coordinated by the State Key Laboratory for Infectious Disease Prevention and Control, Chinese Centre for Disease Control and Prevention, National Institute for Communicable Disease Control and Prevention, Beijing, People\'s Republic of China (ICDC). Eight participating cities and provinces in mainland China including Guangdong, Guangxi, Henan, Fujian, Sichuan, Beijing, Shanghai and Chongqing were involved in *Salmonella* isolation. All isolates were recovered within the period 2005--2011. All experimental protocols were approved and performed in accordance to the approved guidelines of Chinese Centre for Disease Control and Prevention.

2.2. Serotyping {#sec2.2}
---------------

*Salmonella* serotyping was conducted by the slide agglutination approach, using *Salmonella* antisera (S & A Reagents Lab Ltd., Bangkok, Thailand) according to the Kaufman-White scheme.

2.3. PCR detection of *oqxAB* {#sec2.3}
-----------------------------

All isolated *Salmonella* strains were subjected to PCR assay to test the presence of the *oqxA* and *oqxB* genes using the primers *oqxA*-F (5′-GACAGCGTCGCACAGAATG-3′), oqxA-R (5′-GCGTGGCTTTGAACTCTGC-3′), and oqxB-F5′-TTCTCCCCCGGCGGGAAGTAC, oqxB-R (5′-CTCGGCCATTTTGGCGC GTA) for *oqxA* and *oqxB* respectively \[[@bib8], [@bib31]\]. Positive detection of either one or both genes was considered as *oqxAB* positive for the *Salmonella* isolates.

2.4. Antimicrobial susceptibility tests {#sec2.4}
---------------------------------------

Minimal inhibitory concentration (MIC) was tested by the microdilution method according to the guidelines of the Clinical and Laboratory Standards Institute (CLSI) [@bib32]. The MIC interpretative criteria were adopted from CLSI. *Escherichia coli* ATCC 25922 was used as control strains in determining MIC values. The following antimicrobial agents were tested (concentration range in mg/L): ampicillin (2--128), Amoxicillin/Clavulanic Acid (1--64), tetracycline (2--128), cefazolin (4--128), ceftiofur (0.25--128), ceftriaxone (0.25--128), chloramphenicol (4--128), streptomycin (1--128), kanamycin (1--128), enrofloxacin (0.008--128), ciprofloxacin (0.008--128), olaquindox (0.25--128), gentamicin (2--128), and trimethoprim/sulfamethoxazole (2/38-8/152). All antimicrobial agents were obtained from the China Institute of Veterinary Drug Control (Beijing, China).

2.5. Pulsed-field Gel Electrophoresis (PFGE) {#sec2.5}
--------------------------------------------

The chromosomal DNA of S. Derby, *S.* Indiana, *S.* Typhimurium, and *S.* Enteritidis strains were digested with restriction enzyme XbaI and subjected to PFGE according to the Pulse Net Standardized Laboratory Protocol (U.S. Centers for Disease Control and Prevention, Atlanta, GA) using the CHEF Mapper XA Pulsed Field Gel Electrophoresis System (Bio-Rad). Electrophoresis parameters: 6.0 V/cm, 120°angle, initial and final switch times of 5 and 40s, respectively; run time was 18.5 h at 14 °C. Cluster analysis of PFGE types was performed according to the Dice coefficient method [@bib33] using the InfoQuest FP Software/Version 4.5 (Bio-Rad).

3. Results {#sec3}
==========

3.1. Relative prevalence and serotype profiles of *Salmonellae* in different animal sources {#sec3.1}
-------------------------------------------------------------------------------------------

A total of 1133 *Salmonella* strains were recovered from 5926 animal samples collected from different provinces in China during the period 2003--2011. [Table 1](#tbl1){ref-type="table"} provides a statistical summary of the rate of isolation of *Salmonellae* from different animal sources. *Salmonellae* were most frequently isolated from chicken samples (isolation rate of 26%), followed by duck (15%), pigs (10%) and cows (7%). The overall isolation rate was 19%. Twenty-five *Salmonella* serotypes were identified among the 1133 *Salmonella* isolates, the most prevalent being Enteritidis (415), followed by Pullorum (194), Indiana (132), Derby (120) and Typhimurium (56). [Table 2](#tbl2){ref-type="table"} summarizes the most frequently isolated serotypes in each specimen type; specific serotype appears to be linked to specific animal source, for example, 98% of *S*. Enteritidis, 100% of *S*. Pullorum and 100% of *S*. Indiana strains identified in this work were recovered from chicken, 96% of *S*. Cremieu were recovered from duck, 87% of *S*. Derby and 100% of *S*. Fyris originated from pigs; likewise, *S.* Give could only be recovered from pigs and cows.Table 1Yearly isolation rate and source distribution of animal *Salmonella* isolates tested in this study.Table 1YearNumber of isolates by Sources\
(Number of samples)Total number\
(Number of samples)Chickenpigsduckscows**2003**20 (113)1 (8)0 (0)0 (0)21 (121)**2004**92 (436)12 (130)0 (0)0 (0)104 (566)**2005**89 (349)0 (6)0 (0)0 (0)89 (355)**2006**110 (429)0 (5)0 (0)0 (0)110 (434)**2007**18 (66)30 (298)5 (50)14 (208)67 (622)**2008**257 (930)27 (276)0 (0)0 (0)284 (1206)**2009**157 (563)60 (586)28 (198)0 (0)245 (1347)**2010**70 (210)34 (330)0 (0)0 (0)104 (540)**2011**30 (121)66 (558)13 (56)0 (0)109 (735)**Total by sources**843 (3217)230 (2197)46 (304)14 (208)1133 (5926)**Isolation rate**26.2%10.5%15.1%6.7%19.1%Table 2The most frequently recoverable *Salmonella* serotypes in each type of animal specimen.Table 2AnimalLocation of isolationSpecimen typeNo. of samplesNo. of *Salmonella* isolates recoveredPrevalent serotypes (\# of isolates)**Chicken**Slaughter houseChicken liver and lung540196Pollorum (170), Rough (18), II (4)Slaughter houseIntestinal contents22531Enteritidis (16), Indiana (15),Slaughter houseChicken meats671182Indiana (102), Enteritidis (54), Derby (10), S. Typhimurium (9)**One-day old chick**Chick farm (hatchery)Fecal samples1781434Enteritidis (315), Rough (80), Pollorum (14)**Pig**Pig farmFecal samples1906198Derby (90), S. Typhimurium (27), Enteritidis (25), Give (24), Fyris (20)**Pig**MarketPork29132Derby (15), Typhimurium (11), Enteritidis (5)**Duck**Slaughter houseIntestinal contents30446Cremieu (24), Pollorum (10), Typhimurium (9), Rough (4)**Cow**Cow farmFecal samples20814Give (10), Derby (4)**Total**----59361133Enteritidis (415), Pollorum (194), Indiana (132)

3.2. *Salmonella* serotype prevalence among human clinical isolates {#sec3.2}
-------------------------------------------------------------------

Upon determining the relative prevalence rates of various *Salmonella* serotypes among animal isolates, we sought to check the degree by which they matched the corresponding profiles of human clinical isolates. According to the data provided by CDC in China, the number of clinical *Salmonella* isolates recorded in specific study centers scattered among eight cites or provinces in China increased yearly from 360 in 2005--2163 in 2011 (no human isolate was collected before 2005). Similar to the situation in the US, the two most prevalent serotypes were *S.* Enteritidis and *S.* Typhimurium, which accounted for around 50% of all *Salmonella* infections ([Table 3](#tbl3){ref-type="table"}). *S.* Enteritidis was also the most prevalent among the animal isolates. Other serotypes ranking from the third to tenth place of prevalence in each year of the study period (2005--2011) are listed in [Table 3](#tbl3){ref-type="table"}. Comparing the data of animal and human clinical isolates, four serotypes were found in both groups: *S.* Enteritidis, *S.* Typhimurium, *S.* Derby and *S.* Indiana. Except for *S.* pullorum which is naturally a poultry-specific strain, there are serotypes which were found only among animal isolates but not human clinical isolates: *S.* Give, Fyris and Cremieu. On the contrary, several serotypes such as *S.* Senftenberg and *S.* Weltevreden, which were commonly observed among clinical isolates, were rarely recoverable in animals.Table 3The ten most frequently isolated *Salmonella* serotypes causing human infection in China in each year of the period 2005--2011.Table 3Order of prevalenceSerotype (percentage of all *Salmonella* strains)2005\
(n = 360)2006\
(n = 441)2007\
(n = 515)2008\
(n = 641)2009\
(n = 829)2010\
(n = 1324)2011\
(n = 2163)**1***S.* Enteritidis\
(23.0)*S.* Enteritidis\
(18.4)*S.* Enteritidis\
(30.4)*S.* Enteritidis\
(32.4)*S*. Typhimurium\
(28.0)*S.* Typhimurium\
(31.0)*S.* Enteritidis\
(30.4)**2***S.* Typhimurium\
(20.1)*S.* Typhimurium\
(18.0)*S.* Typhimurium\
(25.7)*S.* Typhimurium\
(26.1)*S.* Enteritidis\
(23.3)*S.* Enteritidis\
(21.3)*S.* Typhimurium\
(25.7)**3***S.* Derby\
(4.5)*S.* Derby\
(3.4)*S.* Derby\
(3.4)*S.* Derby\
(3.0)*S.* Senftenberg\
(5.1)*S.* Derby\
(4.2)*S.* Derby\
(3.4)**4***S.* Anatum\
(2.5)*S.* Anatum\
(2.5)*S.* Anatum\
(2.5)*S.* Anatum\
(2.7)*S.* Agona\
(3.8)*S.* Agona\
(3.2)*S.* Anatum\
(2.5)**5***S.* London\
(2.5)*S.* London\
(2.5)*S.* London\
(2.5)*S.* London\
(2.7)*S.* Derby\
(3.1)*S.* Stanly\
(2.9)*S.* London\
(2.5)**6***S.* Senftenberg\
(2.0)*S.* Senftenberg\
(2.0)*S.* Senftenberg\
(2.0)*S.* Senftenberg\
(2.2)*S.* Stanly\
(2.8)*S.* Senftenberg\
(2.0)*S.* Senftenberg\
(2.0)**7***S.* Weltevreden\
(1.8)*S.* Weltevreden\
(1.8)*S.* Weltevreden\
(1.8)*S.* Weltevreden\
(1.9)*S.* Infantis\
(2.2)*S.* Meleagridis\
(2.0)*S.* Weltevreden\
(1.8)**8***S.* Istanbul\
(1.6)*S.* Istanbul\
(1.6)*S.* Istanbul\
(1.6)*S.* Istanbul\
(1.7)*S.* Thompson\
(1.8)*S*. London\
(1.9)*S.* Istanbul\
(1.6)**9***S.* Thompson\
(1.6)*S.* Thompson\
(1.6)*S.* Thompson\
(1.6)*S.* Thompson\
(1.7)*S.* Newport\
(1.7)*S.* Thompson\
(1.9)*S.* Thompson\
(1.6)**10**S. Agona\
(1.5)*S.* Agona\
(1.5)*S.* Agona\
(1.5)*S.* Agona\
(1.4)*S.* Agona\
(1.4)*S*. Newport\
(1.8)*S.* Agona\
(1.5)

3.3. Antimicrobial susceptibility of different serotypes of *Salmonella* isolated from animal and human {#sec3.3}
-------------------------------------------------------------------------------------------------------

We next compared the antibiotic susceptibility profiles of animals and human clinical isolates to determine whether the vast majority of *Salmonella* strains causing human infections originated from food animals, in which case we expected that the two groups of isolates shared similar antibiotic susceptibility profiles. Our data, depicted in Tables [4](#tbl4){ref-type="table"} and [5](#tbl5){ref-type="table"}, showed that striking similarities and discrepancies in antibiotic susceptibility profiles were both observable when serotypes commonly found in animal and human clinical isolates were compared. *S.* Enteritidis in both groups exhibited similar susceptibility profiles, with the exception that animal *S.* Enteritidis isolates displayed a higher resistance rate to trimethoprim/sulfamethoxazole. Interestingly, low rate of resistance to ciprofloxacin coupled with a high nalidixic acid resistance rate was observable in both animal and human isolates of *S.* Enteritidis. *S.* Typhimurium from both groups also exhibited very similar antimicrobial susceptibility profiles, with the resistance rate being slightly higher among the animal isolates. The most dramatic difference between animal and human *Salmonella* isolates was observed in *S.* Indiana, in which around 92% of animal *S.* Indiana isolates were resistant to ceftriaxone, whereas none of the human isolates was resistant to cephalosporins. The rate of resistance to other antibiotics was also generally higher among animal *S.* Indiana strains (Tables [4](#tbl4){ref-type="table"} and [5](#tbl5){ref-type="table"}).Table 4Resistance rate of commonly identified serotypes of animal *Salmonella* isolates.Table 4Antibiotics% of resistance in different serotypes of *Salmonella*Enteritidis\
n = 415Pollorum\
n = 194Indiana\
n = 132Derby\
n = 120Typhimurium\
n = 56Give\
n = 34Cremieu\
n = 25Fyris\
n = 24Other serotypes\
n = 133Ampicillin35249715829408944Amoxicillin/Clavulanic Acid16368911829109247Cefazolin4139599901519Ceftiofur4379445001918Ceftriaxone4329244001616Chloramphenicol4168148688209233Streptomycin1589229648208933Gentamicin169310687708127Kanamycin37958778508944Tetracycline30529788828509668Nalidixic Acid9986993828209664Ciprofloxacin1357513557408934Sulfisoxazole45971009686941002772Trimethoprim/Sulfamethoxazole49969955828503165Table 5Resistance rate of commonly identified serotypes of human clinical *Salmonella* isolates.Table 5Antibiotic% of resistance in different serotypes of *Salmonella*Enteritidis\
n = 483Typhimurium\
n = 710Derby\
n = 167Senftenberg\
n = 83Weltevreden\
n = 79Newport\
n = 64Agona\
n = 57Anatumn\
= 47Indiana\
n = 25Other serotypes\
n = 38**Ampicillin**4247700015705242**Amoxicillin/Clavulanic Acid**92600005600**Cefazolin**4400000400**Ceftiofur**4400000400**Ceftriaxone**4400000400**Chloramphenicol**6436800010705211**Streptomycin**3152220001266488**Gentamicin**11350000830443**Kanamycin**1544100001543532**Tetracycline**21498901020805224**Nalidixic Acid**9473561310227810026**Ciprofloxacin**0200000010720**Sulfisoxazole**65533140025806432**Trimethoprim/Sulfamethoxazole**2383300010405226

3.4. Features of transmission of animal isolates to human {#sec3.4}
---------------------------------------------------------

To further confirm whether a significant proportion of clinical *Salmonella* strains originated from animals, 40 animal isolates belonging to each of serotypes commonly observed in both groups (*S.* Enteritidis, *S.* Typhimurium, *S.* Derby and *S.* Indiana) were randomly selected and subjected to PFGE typing, and then compared to those of human clinical *Salmonella* strains in the China CDC database ([Fig. 1](#fig1){ref-type="fig"}). For *S.* Enteritidis, half of the 40 animal *S.* Enteritidis isolates were found to belong to the PFGE pattern CN0004, to which 167 out of the 1550 *S.* Enteritidis strains identified in the China CDC also belonged. Likewise, eight out of the 40 animal isolates belonged to CN0003, which was the most prevalent PFGE pattern in human isolates in the CDC database, covering as many as 444 out of the 1550 *S.* Enteritidis isolates in the database. Only 3 animal *S.* Enteritidis strains were found to belong to new PFGE patterns which could not be identified in the CDC database. Identical PFGE patterns were also observable in both animal and human clinical isolates for the serotypes of *S.* Typhimurium and *S.* Indiana, but not *S.* Derby ([Fig. 1](#fig1){ref-type="fig"}).Fig. 1Different serotypes of *Salmonella* isolates with same PFGE patterns were detected in both animal and human clinical isolates. Number in parentheses represents the total number of isolates in the database that have been used in comparison.Fig. 1

3.5. Synchronous emergence of *oqxAB* positive *Salmonella* strains in animals and humans {#sec3.5}
-----------------------------------------------------------------------------------------

The rate of transmission of a newly emerged *Salmonella* strain among animal and humans has never been demonstrated. In a previous study, we have identified a plasmid mediated RND efflux pump, OqxAB, which was found to emerge in *Salmonella* spp.. We showed that the gene encoding this efflux pump (*oqxAB*) began to emerge in clinical *S.* Typhimurium strains in 2006 and that the *oqxAB* positive rate steadily increased from 12% in 2006 to 43% in 2011 [@bib31]. This gene is therefore considered a good marker for determining whether the majority of clinical *Salmonella* strains that cause human infections originated from animals. Screening of the animal isolates showed that the overall prevalence rate of *oqxAB* in *Salmonella* animal isolates was about 18%, with varying positive rate among different serotypes. Consistent with previous findings, no *oqxAB* gene was detectable in the 157 *Salmonella* strains isolated before 2006. *S.* Fyris exhibited the highest *oqxAB* positive rate, reaching 95%. Approximately about 50% of *S*. Typhimurium, *S.* Indiana and *S.* Derby strains were positive for *oqxAB*, whereas *S.* Enteritidis and other serotypes exhibited a very low *oqxAB* positive rate (0.9%) ([Table 6](#tbl6){ref-type="table"}). The simultaneous detection of marker gene *oqxAB* in both animal and human *Salmonella* isolates constitutes evidence of efficient transmission of *Salmonella* among animals and human. Most interestingly, an earlier study in our laboratory has reported the expansion of an *oqxAB*-positive *S.* Typhimurium ST34 clone which belonged to the CN0006 PFGE pattern in both Hong Kong and China [@bib31]. This exact PFGE pattern was also detectable in 14 out of the 40 *S.* Typhimurium animal isolates tested, which were all *oqxAB* positive, suggesting that this specific clone are among the few which can be transmitted most efficiently from animals to human.Table 6The relative *oqxAB* positive rate of five most prevalent serotypes of animal and human clinical *Salmonella* isolates recovered before and after the year 2006.Table 6YearSources*oqxAB* positive rate (number of isolates screened)Overall*S.* Typhimurium*S.* Enteritidis*S.* Derby*S.* Indiana*S.* London**Before 2006Animal isolates**0 (157)0 (20)0 (80)0 (35)0 (20)0 (2)**Human clinical isolates**0 (210)0 (50)0 (100)0 (40)0 (10)0 (10)**2006 onwardAnimal isolates**19% (723)29% (42)0.9% (431)46% (115)48% (130)0 (5)**Human clinical isolates**18% (1143)27% (660)1% (383)29% (70)20% (10)0 (20)

4. Discussion {#sec4}
=============

To date, more than 2700 serotypes of *Salmonella* have been identified, but the ability of each serotype to cause human infections is known to vary significantly [@bib34]. Since *Salmonella* infection is considered a major zoonotic disease, assessment of the differential prevalence of serotypes of animal and human clinical isolates may help depict the relative virulence and transmission potential of major *Salmonella* serotypes and identify strains which exhibit the highest infection risk. Serotype-specific features of *Salmonellae* have been observed in animal, food and clinical isolates. In the US, CDC surveillance data showed that the most prevalent serotypes in clinical isolates were *S.* Enteritidis, *S.* Typhimurium, *S.* Newport and *S.* Javiana, whereas among isolates that cause animal diseases, the most prevalent serotypes were *S.* Typhimurium, *S.* Dublin, *S.* Cerro, *S.* Agona and *S.* Derby [@bib22]. In animal isolates that rarely cause infections in animals, *S.* Kentucky, *S.* Enteritidis and *S.* Senftenberg were the common serotypes [@bib22]. Such discrepancy, which was also observable in our study, is likely due to the wide range of infection potential exhibited by animal *Salmonella* strains, among which only a certain proportion could cause human infections. Alternatively, it could also be due to other factors, such as eating habits that prevent certain food-specific serotypes from causing human infections. These possibilities will be discussed below.

Data on the surveillance of *Salmonella* in pigs in 2000 and 2006 from USDA showed that 6% and 7.2% of the samples were positive to *Salmonella* in these two years respectively, with strains belonging to the serotypes *S.* Derby, *S.* Typhimurium var. 5- and *S*. Agona being the most common. Among such strains, *S.* Derby was commonly resistant to streptomycin, sulfisoxazole, and tetracycline [@bib35]. A similar isolation rate (10.5%), profile of dominant serotypes, and resistance pattern were observed among *Salmonella* strains isolated from pigs in this study. At present, data of surveillance of *Salmonella* recovered from poultry and the corresponding food products were not available in USDA and FDA, although *S.* Enteritidis is considered as a major threat to human health [@bib36]. In this study, *S.* Enteritidis was confirmed to be closely associated with the meat and GI tract of chicken, as well as with one-day old chick, presumably due to the contamination of eggs.

Due to a lack of comprehensive surveillance system in China, the relative prevalence of *Salmonella* serotypes in human and non-human sources is unknown. The present work represents the first attempt to address this issue, with a hope of identifying the major serotypes/zoonotic strains responsible for causing human infections. The fact that the majority of *Salmonella* isolates recovered from one-day old chicks were *S.* Enteritidis supports the idea that *S.* Enteritidis is the major serotype of *Salmonellae* that can cause egg contamination, since organisms residing in one-day old chick are expected to be mainly derived from eggs. Notably, in both chicken and pigs, *Salmonellae* isolated from intestinal content and meat products exhibited similar serotypes, suggesting that contamination of chicken meat and pork by fecal particles of the respective animals is common.

Consistent with the data from NARMS (<https://www.fda.gov/AnimalVeterinary/SafetyHealth/AntimicrobialResistance/NationalAntimicrobialResistanceMonitoringSystem/ucm416741.htm>), we observed a high rate of resistance to tetracycline, ampicillin, sulfamethoxazole, streptomycin and chloramphenicol in both animal and human *Salmonella* strains, with the animal isolates displaying a higher rate of resistance to the majority of the agents tested. Consistent with our findings, data from NARMS also showed that *S*. Enteritidis displayed much lower resistance to most of the antibiotics than *S*. Typhimurium. The most striking difference is that *S*. Enteritidis strains from various sources exhibited very high resistance to nalidixic acid, yet the rate among US strains was very low. The rate of resistance among human *Salmonella* isolates collected in different countries was similar to each other. However, the rate of resistance to ciprofloxacin was strikingly different between animal *S*. Typhimurium strains in the US isolates (∼0.2%) and in China (∼55%). On the other hand, the rate of resistance to cephalosporins among animal isolates, in particular *S*. Typhimurium in the US (∼20%), was much higher than that of China (∼5%).

In this work, human clinical isolates exhibited significantly different profiles of serotype and antimicrobial susceptibility when compared to the animal isolates, suggesting that the infection potential of different serotypes may vary significantly. For instance, several serotypes commonly found among human clinical isolates, such as *S.* Senftenberg and *S.* Weltevreden, were not recoverable in all animal specimens tested. Since these serotypes are prevalent in food samples in Western countries \[[@bib37], [@bib38]\], the possibility that some clinical strains of such serotypes in China originated from imported foods cannot be ruled out. In this work, animal isolates generally exhibited a higher rate of resistance to most antimicrobial compounds. We hypothesize that this phenotypic discrepancy between animal and human clinical isolates may be related to the difference in serotype patterns of animal and human clinical isolates, and may to some extent be due to the reduced physiological fitness of the more resistant animal isolates, which may have limited their abilities to infect humans among the same serotype of *Salmonella* \[[@bib39], [@bib40]\]. From another viewpoint, the high prevalence of antibiotic resistance in zoonotic *Salmonella* strains infers that organisms which end up causing infections in humans are likely to be both drug resistant and physiologically fit, presumably due to acquisition of compensatory mutations [@bib41]. In this work, several common serotypes of animal isolates, such as *S.* Cremieu, *S.* Fyris and *S.* Give, were not found among human clinical isolates. We postulate that the low infection rate of these serotypes may be due to their low infection potential or different host specificity. On the other hand, human *Salmonella* isolates that do not share the same PFGE patterns as animal isolates may originate from other food sources that were not tested in this study. Nevertheless, *S.* Enteritidis and *S.* Typhimurium, which were prevalent in both animal and human clinical isolates, exhibited similar rate of resistance to the test antimicrobials. This finding might suggest that human infections caused by *Salmonella* strains of these two serotypes mainly originated from animals. This idea is further supported by the finding that several PFGE patterns of animal *S.* Enteritidis and *S.* Typhimurium clinical isolates constituted the most prevalent PFGE types among human clinical isolates.

Currently, the efficiency by which a newly emerged strain is transmitted among animal and humans is not known. By screening the *oqxAB* gene in both animal and human isolates, we confirm that this gene started to emerge in both groups from 2006 onwards, with similar prevalence rate being recorded among all the four serotypes, which were commonly found in both animal and human clinical isolates. These data indicated that animal isolates can be spontaneously transmitted from animals to humans or vice versus, bringing along the new genetic features that they have acquired. To summarize, findings in this work suggest that animal-borne *Salmonella* strains, which have the highest potential to cause human infections in China are those which reside in chicken, belong to the serotypes of Enteritidis or Typhimurium, and exhibit moderate to high rate of resistance to antibiotics.
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